Redrawing the borders: Considering guideline revision in functional mitral regurgitation

JACC: Cardiovascular Imaging

Volumn 7, Issue 3, 2014, Pages 333-335

  Marwick, Thomas H ^a   Zoghbi, William A ^b   Narula, Jagat ^c  

^a UNIVERSITY OF TASMANIA   (Australia)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c MOUNT SINAI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COLOR ULTRASOUND FLOWMETRY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EDITORIAL; EVIDENCE BASED PRACTICE; HEART VENTRICLE REMODELING; HUMAN; KIDNEY FAILURE; MEDICAL SOCIETY; MITRAL VALVE REGURGITATION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED STATES; ECHOGRAPHY; EUROPE; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEART LEFT VENTRICLE FUNCTION; MITRAL VALVE INSUFFICIENCY; PATHOLOGY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; STANDARDS;

DELIVERY OF HEALTH CARE; ECHOCARDIOGRAPHY; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; MITRAL VALVE INSUFFICIENCY; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84896502035     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2014.02.002     Document Type: Editorial

References (15)

1. Brook RH. Critical issues in the assessment of quality of care and their relationship to HMOs. J Med Educ 1973;48 Suppl:114-34.
2. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451-96.
3. Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2013;14:611-44.
4. Beigel R, Siegel RJ. Should the guidelines for the assessment of the severity of functional mitral regurgitation be redefined? J Am Coll Cardiol Img 2014;7:313-4.
5. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). J Am Coll Cardiol 2008;52:e1-142.
6. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. A report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force on Valvular Regurgitation. JAmSoc of Echocardiography 2003;16:777-802.
7. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759-64. (Pubitemid 32291413)
8. Marwick TH, Lancellotti P, Pierard L. Ischaemic mitral regurgitation: mechanisms and diagnosis. Heart 2009;95:1711-8.
9. Benedetto U, Melina G, Roscitano A. Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation? A meta-analysis on 2479 patients. J Cardiovasc Med (Hagerstown) 2009;10:109-14.
10. Gada H, Scuffham PA, Griffin B, Marwick TH. Quality-of-life implications of immediate surgery and watchful waiting in asymptomatic aortic stenosis: a decision-analytic model. Circ Cardiovasc Qual Outcomes 2011;4:541-8.
11. Little SH, Igo SR, Pirat B, et al. In vitro validation of real-time three-dimensional color Doppler echocardiography for direct measurement of proximal isovelocity surface area in mitral regurgitation. Am J Cardiol 2007;99:1440-7. (Pubitemid 46686649)
12. Little S, Pirat B, Kumar R, et al. Three-Dimensional color Doppler echocardiography for direct measurement of vena contracta area in mitral regurgitation: in vitro validation and clinical experience. J Am Coll Cardiol Img 2008;1:695-704.
13. Thavendiranathan P, Phelan D, Collier P, et al. Quantitative assessment of mitral regurgitation: how best to do it. J Am Coll Cardiol Img 2012;5:1161-75.
14. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC Jr. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009;301:831-41.
15. Eddy DM, Billings J. The quality of medical evidence: implications for quality of care. Health Aff (Millwood) 1988;7:19-32. (Pubitemid 18080570)